Product Dossier
CYMEVENE
Product Dossier for CYMEVENE (ganciclovir sodium, Pharmaco). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Pharmaco
- Active ingredient: ganciclovir sodium
- Therapeutic area: Infectious Disease
- Same area: FETROJA
- Same area: ROXAR
What it is
Cymevene is ganciclovir 500 mg (as sodium) powder for injection.
PBS listing
Cymevene 500 mg powder for intravenous infusion is listed on the PBS with streamlined restriction, with an ex-manufacturer price of A$116.09.
Regulatory history
Cymevene was first registered on the ARTG on 11 June 1991.